Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeonsâ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
髿é·
å瀟ã®åçã¯éå»3幎éã«ãããçå®ã«å¢å ããŠããã幎平åã§24.67%ã®æé·çã瀺ããŠããŸãã
é»å転æ
å瀟ã¯é»å転æãæãããææ°ã®å¹ŽéçŽå©çã¯USD ã§ãã
å²é«
åç€Ÿã®ææ°ã®PEã¯91.78ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠé«å€åã«ãããŸãã
æ©é¢æè³å®¶ã®è²·ãå¢ã
ææ°ã®æ©é¢æè³å®¶ã®ä¿ææ ªæ°ã¯45.29Mæ ªã§ãåååææ¯ã§1.10%å¢å ããŠããŸãã
ãã£ãã¯ã»ãã€ã¹ãä¿æ
ã¹ã¿ãŒæè³å®¶ãã£ãã¯ã»ãã€ã¹ã¯æ¬éæã684.09Kæ ªä¿æããŠããŸãã
åžå ޿޻åãæŽ»çº
å瀟ãžã®æè³å®¶ã®é¢å¿ãé«ãŸã£ãŠããã20æ¥éã®å£²è²·å転çã¯1.13ã§ãã